BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lam T, Burns K, Dennis M, Cheung NW, Gunton JE. Assessment of cardiovascular risk in diabetes: Risk scores and provocative testing. World J Diabetes 2015; 6(4): 634-641 [PMID: 25987961 DOI: 10.4239/wjd.v6.i4.634]
URL: https://www.wjgnet.com/1948-9358/full/v6/i4/634.htm
Number Citing Articles
1
S. Kou, J.Y. Cao, S. Yeo, D.J. Holmes-Walker, S.L. Lau, J.E. Gunton. Ethnicity influences cardiovascular outcomes and complications in patients with type 2 diabetesJournal of Diabetes and its Complications 2018; 32(2): 144 doi: 10.1016/j.jdiacomp.2017.10.016
2
Chanchal Chandramouli, Melissa E. Reichelt, Claire L. Curl, Upasna Varma, Laura A. Bienvenu, Parisa Koutsifeli, Antonia J. A. Raaijmakers, Miles J. De Blasio, Cheng Xue Qin, Alicia J. Jenkins, Rebecca H. Ritchie, Kimberley M. Mellor, Lea M. D. Delbridge. Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemiaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20703-8
3
Marco Herbsleb, Andy Schumann, Berend Malchow, Christian Puta, P. Christian Schulze, Holger W. Gabriel, Karl-Jürgen Bär. Chronotropic incompetence of the heart is associated with exercise intolerance in patients with schizophreniaSchizophrenia Research 2018; 197: 162 doi: 10.1016/j.schres.2018.02.020
4
Marie-Claire Fava, Sascha Reiff, Joseph Azzopardi, Stephen Fava. Time trajectories of key cardiometabolic parameters and of cardiovascular risk in subjects with diabetes in a real world settingDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2023; 17(6): 102777 doi: 10.1016/j.dsx.2023.102777
5
Karolina Tchórzewska, Jakub Tchórzewski, Adam Rzeźnicki, Dominika Cichońska-Rzeźnicka, Andrzej Szpak, Jan Krakowiak. Dissemination of Selected Risk Factors for Cardiovascular Diseases Among Patients Using Primary Health Care in the Lodz VoivodeshipJournal of Health Study and Medicine 2023; 2023(1): 21 doi: 10.2478/jhsm-2023-0002
6
Hana Kahleova, Terezie Pelikanova. Vegetarian and Plant-Based Diets in Health and Disease Prevention2017; : 369 doi: 10.1016/B978-0-12-803968-7.00021-6
7
Nebojsa Kavaric, Aleksandra Klisic, Ana Ninic. Cardiovascular risk estimated by UKPDS risk engine algorithm in diabetesOpen Medicine 2018; 13(1): 610 doi: 10.1515/med-2018-0086
8
Ehimen Phyllis Odum, Ekenechukwu Esther Young. Elevated cardiac troponin I, creatine kinase and myoglobin and their relationship with cardiovascular risk factors in patients with type 2 diabetesDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(2): 141 doi: 10.1016/j.dsx.2017.12.001
9
James J. Chamberlain, Eric L. Johnson, Sandra Leal, Andrew S. Rhinehart, Jay H. Shubrook, Lacie Peterson. Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018Annals of Internal Medicine 2018; 168(9): 640 doi: 10.7326/M18-0222
10
Christos Damaskos, Nikolaos Garmpis, Paraskevi Kollia, Georgios Mitsiopoulos, Danai Barlampa, Athanasios Drosos, Alexandros Patsouras, Nikolaos Gravvanis, Vasileios Antoniou, Alexandros Litos, Evangelos Diamantis. Assessing Cardiovascular Risk in Patients with Diabetes: An UpdateCurrent Cardiology Reviews 2021; 16(4): 266 doi: 10.2174/1573403X15666191111123622
11
Yazid N. Al Hamarneh, Brenda R. Hemmelgarn, Imran Hassan, Charlotte A. Jones, Ross T. Tsuyuki. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled R x EACH TrialCanadian Journal of Diabetes 2017; 41(6): 580 doi: 10.1016/j.jcjd.2017.08.244
12
Meghan A Jardine, Hana Kahleova, Susan M Levin, Zeeshan Ali, Caroline B Trapp, Neal D Barnard. Perspective: Plant-Based Eating Pattern for Type 2 Diabetes Prevention and Treatment: Efficacy, Mechanisms, and Practical ConsiderationsAdvances in Nutrition 2021; 12(6): 2045 doi: 10.1093/advances/nmab063
13
Amel Fayed, Rasmieh Alzeidan, Roaa Elkouny, Marwa Tawfik, Rania Naguib. Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) StudyInternational Journal of General Medicine 2023; : 1171 doi: 10.2147/IJGM.S404054
14
Atsuko Yokota, Shuji Gamoh, Naoko Tanaka-Totoribe, Tatsuo Shiba, Masachika Kuwabara, Eisaku Nakamura, Takahiro Hayase, Hiroaki Hisa, Kunihide Nakamura, Ryuichi Yamamoto. Angiotensin II, as well as 5-hydroxytriptamine, is a potent vasospasm inducer of saphenous vein graft for coronary artery bypass grafting in patients with diabetes mellitusBiochemistry and Biophysics Reports 2016; 6: 82 doi: 10.1016/j.bbrep.2016.03.008